Adam Kasper v. HHS - Influenza, Guillain-Barré Syndrome (2025)

Adam Kasper filed a petition for compensation under the National Vaccine Injury Compensation Program on January 26, 2024. He alleged that he suffered Guillain-Barré Syndrome (GBS), a condition listed on the Vaccine Injury Table, after receiving an influenza vaccine on November 7, 2021.

Mr. Kasper also alleged that he received the vaccine in the United States, suffered residual effects of his GBS for more than six months, and had not filed a civil action or received compensation for his illness.

The case was assigned to the Special Processing Unit. On October 7, 2024, the Respondent, the Secretary of Health and Human Services, filed a Rule 4(c) Report conceding that Mr.

Kasper was entitled to compensation. The Respondent stated that Mr.

Kasper satisfied the criteria set forth in the Vaccine Injury Table and Qualifications and Aids to Interpretation. On October 8, 2024, Chief Special Master Brian H.

Corcoran issued a Ruling on Entitlement, finding Mr. Kasper entitled to compensation.

Subsequently, on February 10, 2025, the Respondent filed a proffer on the award of compensation. Mr.

Kasper agreed to the proffered award. On March 14, 2025, Chief Special Master Corcoran issued a Decision Awarding Damages.

The court awarded Mr. Kasper a total of $124,485.55.

This amount was comprised of $122,500.00 for pain and suffering, $1,030.00 for past unreimbursable expenses, and $955.55 for past lost wages. The award was to be paid as a lump sum through an ACH deposit to Mr.

Kasper's counsel's IOLTA account for prompt disbursement. Petitioner was represented by Maximillian J.

Muller of Muller Brazil, LLP, and Respondent was represented by Margaret Armstrong of the U.S. Department of Justice.

The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of causation beyond it being a Table injury.